Cell Signaling Technology

GRK6 (D1A4) Rabbit Monoclonal Antibody

#5878 · $159,352

100

Citing papers

10.2k

Combined citations

Supplier page Find this product

Research areas

MicroRNA in disease regulation19 HER2/EGFR in Cancer Research8 Cancer-related molecular mechanisms research8 Cell Adhesion Molecules Research8 Circular RNAs in diseases7 Monoclonal and Polyclonal Antibodies Research7 Cell death mechanisms and regulation6 Caveolin-1 and cellular processes6

Papers citing this product

1

AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells

Nature Communications·2019·360 cit.·DOI

2

Discovery and Pharmacological Characterization of JNJ-42756493 (Erdafitinib), a Functionally Selective Small-Molecule FGFR Family Inhibitor

Molecular Cancer Therapeutics·2017·338 cit.·DOI

3

Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer

American Journal Of Pathology·2012·323 cit.·DOI

4

Different mechanisms for resistance to trastuzumab versus lapatinib in HER2- positive breast cancers - role of estrogen receptor and HER2 reactivation

Breast Cancer Research·2011·283 cit.·DOI

5

Antitumor activity and pharmacokinetic properties of PF-00299804, a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor

Molecular Cancer Therapeutics·2008·221 cit.·DOI

6

Phosphatidylserine exposure during apoptosis reflects bidirectional trafficking between plasma membrane and cytoplasm

Cell Death and Differentiation·2012·215 cit.·DOI

7

Hypoxia- and Vascular Endothelial Growth Factor-Induced Stromal Cell-Derived Factor-1α/CXCR4 Expression in Glioblastomas

American Journal Of Pathology·2008·208 cit.·DOI

8

Identification and activation of TLR4-mediated signalling pathways by alginate-derived guluronate oligosaccharide in RAW264.7 macrophages

Scientific Reports·2017·198 cit.·DOI

9

MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN

Carcinogenesis·2012·190 cit.·DOI

10

Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer

Breast Cancer Research·2011·184 cit.·DOI

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.